Records containing: Thyroid Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-01-28The Efficacy and Safety of Anlotinib Hydrochloride or Penpulimab In Combination With RAI in Patients With Local Advanced or Metastatic Differentiated Thyroid Cancer: A Randomized, Open-label, Exploratory Clinical Trial
-
CLINICAL_TRIALS study record update · 2022-01-20Study of Apatinib in Patients With Local Advanced/Metastatic Iodine-131（131I）-Refractory/Resistant Differentiated Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2022-01-06Shared Decision Making in Patients With Thyroid Nodules
-
CLINICAL_TRIALS study record update · 2021-11-18Assessment of CA19-9 in Patients' With Thyroid Malignancies
-
CLINICAL_TRIALS study record update · 2021-10-15UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-09-28A Phase II Trial Using RAD001 for Patients With Radioiodine Refractory Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2021-09-23Psycho-oncological Intervention Through Counselling in Patients With Differentiated Thyroid Cancer in Treatment With Radioiodine: A Non-randomized Controlled Study
-
CLINICAL_TRIALS study record update · 2021-09-21Cell-free Tumor DNAand HPV-DNA in Blood Samples From Newly Diagnosed Patients With Head and Neck Cancer
-
CLINICAL_TRIALS study record update · 2021-09-13Prospective, Blinded, Multi-center Clincal Study of NGS-based Thyroscan Genomic Classifier in the Diagnosis of Thyroid Nodules
-
CLINICAL_TRIALS study record update · 2021-09-05Prospective Validation of the Molecular Classifier for the Fine Needle-based Assessment of Malignancy Risk in Thyroid Nodules
-
CLINICAL_TRIALS study record update · 2021-08-27Estimation of Economic Consequences Linked With Different Care Management Pathways of Differentiated Thyroid Cancers : Involvement of Overtreatment
-
CLINICAL_TRIALS study record update · 2021-08-25A Prospective Randomized Controlled Study of Whether Anti-adhesion Barrier Can Prevent Voice Quality After Thyroidectomy.
-
CLINICAL_TRIALS study record update · 2021-07-06Anaplastic Thyroid Cancer and Follicular Thyroid Cancer-derived Exosomal Analysis Via Treatment of Lovastatin and Vildagliptin and Pilot Prognostic Study Via Urine Exosomal Biological Markers in Thyroid Cancer Patients
-
CLINICAL_TRIALS study record update · 2021-06-16Phase 2 Clinical Trial of Bi-weekly Dosing of Irofulven Plus Capecitabine in Patients With Anaplastic or Locally Advanced/Metastatic Differentiated Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2021-06-01A New Scoring System in the Diagnosis of Thyroid Gland Pathologies
-
CLINICAL_TRIALS study record update · 2021-05-11Minimizing Narcotic Analgesics After Thyroid or Parathyroid Surgery
-
CLINICAL_TRIALS study record update · 2021-05-10Salivary dysfuncTion After Radioiodine Treatment
-
CLINICAL_TRIALS study record update · 2021-04-01The Efficacy and Safety of Anlotinib in Neoadjuvant Treatment in Locally Advanced Thyroid Cancer: a Single-arm Phase II Clinical Trial
-
CLINICAL_TRIALS study record update · 2021-03-19A Multicenter Prospective Controlled Trial of Laser Ablation Versus Surgery for the Treatment of Papillary Thyroid Microcarcinoma
-
CLINICAL_TRIALS study record update · 2021-03-17The Risk Stratification of Papillary Thyroid Cancer With Bethesda Category III（AUS/FLUS）by Thyroid Fine-Needle Aspiration（FNA）Could be Assisted by Tumor Size for Precision Treatment
-
CLINICAL_TRIALS study record update · 2021-03-05Phase II Clinical Trial in Radioactive Iodine-Refractory Advanced Thyroid Carcinoma Evaluating BRAF & MEK Blockade Therapy for Re-differentiation- Applying a Novel Time-Dependent Concept
-
CLINICAL_TRIALS study record update · 2021-02-18Khon Kaen University's Thyroidectomy Registry
-
CLINICAL_TRIALS study record update · 2021-01-29Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis)
-
CLINICAL_TRIALS study record update · 2021-01-22Adaptive Tyrosine Kinase Inhibitor Therapy In Patients With Advanced Progressive Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2021-01-11A Multicenter, Randomized, Double-Blind Phase 2 Trial of Lenvatinib (E7080) in Subjects With 131I-Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24-mg Starting Dose, But Have a Better Safety Profile